A Dose-escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetic of LPM3770164 in Healthy Subjects
Condition(s):Huntington Disease; Tardive DyskinesiaLast Updated:January 29, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Huntington Disease; Tardive DyskinesiaLast Updated:January 29, 2024Completed
Condition(s):Huntington’s Disease; Tourette SyndromeLast Updated:January 22, 2020Completed
Condition(s):Tardive Dyskinesia; Huntington DiseaseLast Updated:January 22, 2024Recruiting
Condition(s):Essential Tremor; Parkinson Disease; Huntington Disease; Dystonia, Primary; Spinocerebellar Ataxias; Movement DisordersLast Updated:September 21, 2022Recruiting
Condition(s):Spinocerebellar Ataxias; Cerebellar Ataxia; Nucleotide Repeat DiseaseLast Updated:September 13, 2023Recruiting
Condition(s):Frontotemporal Dementia; Huntington Disease; Alzheimer Disease; Semantic Dementia; Dementia, VascularLast Updated:July 20, 2020Completed
Condition(s):Alzheimer’s Disease; Amyotrophic Lateral Sclerosis; Brain Injury; Huntington’s Disease; Multiple Sclerosis; Parkinson’s Disease; Stroke; Spinal Cord InjuryLast Updated:September 26, 2018Completed
Condition(s):Parkinson Disease; Huntington Disease; Autistic Spectrum Disorders; Fragile X Syndrome; Alzheimer Disease; Mild Cognitive ImpairmentLast Updated:January 6, 2017Completed
Condition(s):Alzheimer Disease; Parkinson Disease; Frontal Dementia; Huntington Disease; Traumatic Brain Injury; StrokeLast Updated:October 21, 2019Terminated
Condition(s):Neurodegenerative Disease; Weight Loss; Amyotrophic Lateral Sclerosis; Parkinson’s Disease; Huntington’s Disease; CachexiaLast Updated:April 20, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.